Morningstar Rating

Stock Research and Analysis

by Bill Buhr
Dentsply International remains the global leader in dental products. Given the company's large product portfolio and history of innovation, we think it will have little trouble maintaining its crown.

Formed from a merger 15 years ago, Dentsply has   Read more 

Bulls Say

Dentsply is the leader in the global market for dental products, with about 17% share.
The company operates in a stable industry that demonstrates generally consistent operating performance, even in the face of economic downturns.
A reduction in the number of dealers in its network has allowed the company to obtain more detailed customer data to better target its products to meet customer needs. Read more 

Bears Say

Lingering economic weakness would affect certain products--particularly those used in cosmetic procedures--and could weigh down overall growth going forward.
Dentsply will continue to generate growth through acquisitions, which carries the risk that the firm will overpay for businesses.
Dentsply generates almost 60% of revenue in foreign markets, which exposes it to fluctuations in foreign currencies. Read more 

Strategy

Dentsply looks to maintain its strong presence in dental products by aggressively rolling out new products each year. The company will focus on the implant market and will look to increase sales abroad,  Read more 

Management

Bret Wise took over as CEO and chairman after Gary Kunkle retired in December 2006. Wise has been with the company since 2002 and served in various capacities prior to becoming CEO, including COO and CFO. Wise earned roughly $4 million in 2008, with   Read more 

Profile

Dentsply is a global leader in the dental product market. The company designs and distributes dental consumables, laboratory equipment, and specialty products and sells   Read more 

First Name
Last Name
Email Address
Zip Code
Create Password
Verify Password
(6-15 characters; case sensitive)

Dodge & Cox: Health Care Now More Attractive 
Watch more 

View all of our analyst reports with a free trial to Morningstar.com Premium.